サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1743895

豚用ワクチンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測、2025年～2033年

Global Swine Vaccines Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 141 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
豚用ワクチンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測、2025年～2033年
出版日: 2025年06月01日
発行: Value Market Research
ページ情報: 英文 141 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

豚用ワクチンの世界市場規模は、2024年の21億6,000万米ドルから2033年には34億9,000万米ドルに成長すると予測され、2026年から2033年の予測期間中に5.49％の堅調な年間平均成長率（CAGR）を示します。

豚用ワクチン市場は、豚の個体群に影響を及ぼす感染症の流行が増加していることを背景に、力強い成長を遂げようとしています。豚肉の世界の需要が増加し続ける中、豚群の健康と生産性を確保するための効果的なワクチン戦略の必要性が最も重要になっています。新種の病原体の出現や、以前はコントロールされていた疾患の調査復活により、ワクチン製剤の研究開発が継続的に必要となっています。企業は、有効性と安全性の向上を約束する組み換えワクチンやmRNAベースのソリューションなどの革新的技術に多額の投資を行っており、養豚生産者が直面する新たな課題に取り組んでいます。

さらに、畜産農家のバイオセキュリティ対策に対する意識の高まりが、養豚用ワクチン市場に大きな影響を与えています。生産者は、包括的な牛群管理戦略の重要な要素として、ワクチン接種の重要性を認識しつつあります。このような考え方の変化は、疾患予防への積極的なアプローチを促進し、ワクチン接種率の向上、ひいては豚群の回復力強化につながっています。ワクチン接種スケジュールをモニタリング・管理するためのデジタルツールの統合も普及しており、酪農家は牛群の健康管理を最適化し、全体的な生産性を向上させることができます。

さらに、世界の養豚産業、特に新興市場の拡大は、豚用ワクチン市場に有利な機会をもたらしています。各国が消費者の需要増に対応するため畜産能力の強化に努める中、高度なワクチン接種プログラムの導入が不可欠となっています。ワクチン製造業者と農業団体間の協力により、これらの地域における知識の移転が促進され、ワクチン接種技術へのアクセスが改善されることが期待されます。豚用ワクチン市場の将来は、継続的な技術革新、疾患管理に対する意識の高まり、動物の健康と福祉の向上へのコミットメントを特徴とし、有望と思われます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供できるよう、綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 豚用ワクチン産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 豚用ワクチンの世界市場分析：製品別

  • 概要：製品別
  • 実績・予測データ分析：製品別
  • 不活化ワクチン
  • 弱毒生ワクチン
  • 組換えワクチン
  • サブユニットワクチン
  • トキソイドワクチン
  • その他

第6章 豚用ワクチンの世界市場分析：疾患タイプ別

  • 概要：疾患タイプ別
  • 実績・予測データ分析：疾患タイプ別
  • PRRS
  • PCV2
  • 豚マイコプラズマ肺炎
  • CSF
  • 豚インフルエンザ
  • 丹毒
  • FMD
  • ASF
  • 豚パルボウイルス
  • その他

第7章 豚用ワクチンの世界市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 実績・予測データ分析：エンドユーザー別
  • 動物病院・クリニック
  • 養豚場
  • 研究機関

第8章 豚用ワクチンの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 豚用ワクチン企業の競合情勢

  • 豚用ワクチン市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Biogenesis Bago
  • Bioveta
  • Boehringer Ingelheim International GmbH
  • Ceva SantA（C）Animale
  • Elanco Animal Health Incorporated
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova
  • Virbac
  • Zoetis Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Inactivated vaccines Market Sales By Geography (USD MN)
  • Live attenuated vaccines Market Sales By Geography (USD MN)
  • Recombinant vaccines Market Sales By Geography (USD MN)
  • Subunit vaccines Market Sales By Geography (USD MN)
  • Toxoid vaccines Market Sales By Geography (USD MN)
  • Other products Market Sales By Geography (USD MN)
  • Analysis By Disease Type (USD MN)
  • Porcine reproductive and respiratory syndrome (PRRS) Market Sales By Geography (USD MN)
  • Porcine circovirus type 2 (PCV2) Market Sales By Geography (USD MN)
  • Mycoplasma hyopneumoniae Market Sales By Geography (USD MN)
  • Classical swine fever (CSF) Market Sales By Geography (USD MN)
  • Swine influenza Market Sales By Geography (USD MN)
  • Erysipelas Market Sales By Geography (USD MN)
  • Foot-and-Mouth disease (FMD) Market Sales By Geography (USD MN)
  • African swine fever (ASF) Market Sales By Geography (USD MN)
  • Porcine parvovirus Market Sales By Geography (USD MN)
  • Other disease types Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Veterinary hospitals & clinics Market Sales By Geography (USD MN)
  • Swine farms Market Sales By Geography (USD MN)
  • Research institutes Market Sales By Geography (USD MN)
  • Global Swine Vaccines Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Swine Vaccines Report
  • Market Research Process
  • Market Research Methodology
  • Global Swine Vaccines Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Inactivated vaccines Market Sales By Geography (USD MN)
  • Live attenuated vaccines Market Sales By Geography (USD MN)
  • Recombinant vaccines Market Sales By Geography (USD MN)
  • Subunit vaccines Market Sales By Geography (USD MN)
  • Toxoid vaccines Market Sales By Geography (USD MN)
  • Other products Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Type (USD MN)
  • Porcine reproductive and respiratory syndrome (PRRS) Market Sales By Geography (USD MN)
  • Porcine circovirus type 2 (PCV2) Market Sales By Geography (USD MN)
  • Mycoplasma hyopneumoniae Market Sales By Geography (USD MN)
  • Classical swine fever (CSF) Market Sales By Geography (USD MN)
  • Swine influenza Market Sales By Geography (USD MN)
  • Erysipelas Market Sales By Geography (USD MN)
  • Foot-and-Mouth disease (FMD) Market Sales By Geography (USD MN)
  • African swine fever (ASF) Market Sales By Geography (USD MN)
  • Porcine parvovirus Market Sales By Geography (USD MN)
  • Other disease types Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Veterinary hospitals & clinics Market Sales By Geography (USD MN)
  • Swine farms Market Sales By Geography (USD MN)
  • Research institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11214069

Global Swine Vaccines Market size is anticipated to grow from USD 2.16 Billion in 2024 to USD 3.49 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.49% during the forecast period of 2026 to 2033.

The swine vaccines market is set for robust growth, driven by the increasing prevalence of infectious diseases affecting pig populations. As the global demand for pork continues to rise, the need for effective vaccination strategies to ensure herd health and productivity becomes paramount. The emergence of novel pathogens and the resurgence of previously controlled diseases necessitate ongoing research and development in vaccine formulations. Companies are investing heavily in innovative technologies, such as recombinant vaccines and mRNA-based solutions, which promise enhanced efficacy and safety profiles, thereby addressing the evolving challenges faced by swine producers.

Moreover, the growing awareness of biosecurity measures among livestock farmers is significantly influencing the swine vaccines market. Producers are increasingly recognizing the importance of vaccination as a critical component of comprehensive herd management strategies. This shift in mindset is fostering a proactive approach to disease prevention, leading to higher vaccination rates and, consequently, a more resilient swine population. The integration of digital tools for monitoring and managing vaccination schedules is also gaining traction, enabling farmers to optimize their herd health management practices and improve overall productivity.

Additionally, the expansion of the global swine industry, particularly in emerging markets, presents lucrative opportunities for the swine vaccines market. As countries strive to enhance their livestock production capabilities to meet growing consumer demand, the adoption of advanced vaccination programs becomes essential. Collaborations between vaccine manufacturers and agricultural organizations are expected to facilitate knowledge transfer and improve access to vaccination technologies in these regions. The future of the swine vaccines market appears promising, characterized by continuous innovation, increased awareness of disease management, and a commitment to enhancing animal health and welfare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Inactivated vaccines
  • Live attenuated vaccines
  • Recombinant vaccines
  • Subunit vaccines
  • Toxoid vaccines
  • Other products

By Disease Type

  • Porcine reproductive and respiratory syndrome (PRRS)
  • Porcine circovirus type 2 (PCV2)
  • Mycoplasma hyopneumoniae
  • Classical swine fever (CSF)
  • Swine influenza
  • Erysipelas
  • Foot-and-Mouth disease (FMD)
  • African swine fever (ASF)
  • Porcine parvovirus
  • Other disease types

By End-user

  • Veterinary hospitals & clinics
  • Swine farms
  • Research institutes
  • COMPANIES PROFILED
  • Biogenesis Bago
  • Bioveta
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova
  • Virbac
  • Zoetis Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SWINE VACCINES INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SWINE VACCINES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Inactivated vaccines Historic and Forecast Sales By Regions
  • 5.4. Live attenuated vaccines Historic and Forecast Sales By Regions
  • 5.5. Recombinant vaccines Historic and Forecast Sales By Regions
  • 5.6. Subunit vaccines Historic and Forecast Sales By Regions
  • 5.7. Toxoid vaccines Historic and Forecast Sales By Regions
  • 5.8. Other products Historic and Forecast Sales By Regions

6. GLOBAL SWINE VACCINES MARKET ANALYSIS BY DISEASE TYPE

  • 6.1. Overview By Disease Type
  • 6.2. Historical and Forecast Data Analysis By Disease Type
  • 6.3. Porcine reproductive and respiratory syndrome (PRRS) Historic and Forecast Sales By Regions
  • 6.4. Porcine circovirus type 2 (PCV2) Historic and Forecast Sales By Regions
  • 6.5. Mycoplasma hyopneumoniae Historic and Forecast Sales By Regions
  • 6.6. Classical swine fever (CSF) Historic and Forecast Sales By Regions
  • 6.7. Swine influenza Historic and Forecast Sales By Regions
  • 6.8. Erysipelas Historic and Forecast Sales By Regions
  • 6.9. Foot-and-Mouth disease (FMD) Historic and Forecast Sales By Regions
  • 6.10. African swine fever (ASF) Historic and Forecast Sales By Regions
  • 6.11. Porcine parvovirus Historic and Forecast Sales By Regions
  • 6.12. Other disease types Historic and Forecast Sales By Regions

7. GLOBAL SWINE VACCINES MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Veterinary hospitals & clinics Historic and Forecast Sales By Regions
  • 7.4. Swine farms Historic and Forecast Sales By Regions
  • 7.5. Research institutes Historic and Forecast Sales By Regions

8. GLOBAL SWINE VACCINES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SWINE VACCINES COMPANIES

  • 9.1. Swine Vaccines Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF SWINE VACCINES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Biogenesis Bago
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Bioveta
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Boehringer Ingelheim International GmbH
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Ceva SantA(C) Animale
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Elanco Animal Health Incorporated
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. HIPRA
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Indian Immunologicals Limited
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Merck & Co. Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Phibro Animal Health Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Vaxxinova
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Virbac
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Zoetis Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies